Abbott hosts conference call for third-quarter earnings
Abbott Laboratories ABT
News
Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
This test screens for 50 cancers - but whether Medicare and other health insurers will cover it hinges on FDA approval
Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
Abbott declares 411th consecutive quarterly dividend
Abbott to Pay $385 Million to Resolve Baby Formula Contamination Claims
Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall
Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm
Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott to Pay $670 Million to Settle Baby-Formula Litigation
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis
Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
Abbott Laboratories Up Over 11%, on Pace for Largest Percent Increase Since July 2002 — Data Talk
Abbott Laboratories 2Q Sales Rise on Diagnostics Growth
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
United States